Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.034 AUD | -2.86% | -12.82% | -64.95% |
06-19 | Biotron's HIV Therapy Meets Primary Endpoints in Phase Two Trial; Shares Rally 15% | MT |
04-05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-64.95% | 21.4M | |
+21.65% | 127B | |
+24.51% | 117B | |
+26.75% | 27.67B | |
-18.35% | 20.33B | |
-15.36% | 16.79B | |
-17.65% | 15.63B | |
+13.54% | 14.84B | |
-47.10% | 14.65B | |
+57.33% | 14.43B |
- Stock Market
- Equities
- BIT Stock
- News Biotron Limited
- Biotron Completes Enrollment for Phase 2 HIV Trial; Shares Jump 7%